Archive: News
-
A Survey of Patient Presentation, Testing, and Diagnosis in ESCC
Broad discussion from John Marshall, MD, on the current standards of diagnosis care in esophageal squamous cell carcinoma (ESCC).
Category: News
-
The Ruesch Report
Welcome to The Ruesch Report, the e-newsletter from the Ruesch Center for the Cure of Gastrointestinal Cancers. We hope you'll take a few minutes to read our past Ruesch Report Issue e-newsletters. W
Category: News
-
ASCO GI22: Pivotal Studies in Pancreatic Cancer with Dr. Marcus Noel
Dr. Marcus Noel summarizes the latest pancreatic cancer developments and data from the ASCO Gastrointestinal Cancers Symposium 2022.
Category: News
-
ASCO GI22: Pivital Studies in Pancreatic Cancer with Dr. Benjamin Weinberg
Dr. Benjamin Weinberg discusses the data from the TRYbeCA-1, KRYSTAL-1 and CISPD3 trials, which were presented at the ASCO Gastrointestinal Cancers Symposium 2022.
Category: News
-
John Marshall, MD- ASCO GI22: Immune Checkpoint Inhibitors and Neoadjuvant Treatment Options for Esophageal Cancer
Dr. John marshall summarizes the latest developments and data from the ASCO GI Cancers Symposium 2022
Category: News
-
ASCO GI22: Recent Advances in Upper Gastrointestinal Cancers
Dr. John L. Marshall summarises the latest developments and data from the ASCO Gastrointestinal Cancers Symposium 2022
Category: News
-
A Proclamation on National Colorectal Cancer Awareness Month, 2022
“During National Colorectal Cancer Awareness Month, I urge every American to exercise vigilance around their own health and the health of their loved ones. Early diagnosis and treatment save lives — and getting screened for colorectal cancer is vitally important as we continue our shared mission to end cancer as we know it.” President Biden
Category: News
-
Liza and John Marshall- Discuss “Off Our Chests”
After Liza Alexander Marshall’s triple-negative breast cancer diagnosis, her oncologist husband had to shift perspective from doctor to caregiver.
Category: News
-
Biomarkers in GI Cancer
Watch this on-demand webcast from a live satellite symposium covering the latest in biomarker testing and the use of targeted therapeutics in gastrointestinal cancers.
Category: News
-
Patients With Neuroendocrine Tumors May ‘Achieve the Cure’ With Liver-Directed Therapies
For patients with neuroendocrine tumors that have spread, curating a liver-directed approach may make their treatment process less risky and less invasive, according to Dr. Emil Cohen
Category: News